Overview
Disseminated strongyloidiasis is a severe systemic infection caused by the nematode Strongyloides stercoralis, characterized by widespread larval migration and potential hyperinfection, particularly in immunocompromised individuals 1.Diagnosis
Identification of Strongyloides stercoralis larvae in stool samples via microscopy or concentration techniques 1.
Serological tests for Strongyloides-specific antibodies can aid in diagnosis, especially in chronic cases 1.
Imaging studies may reveal arteritis or other complications in severe disseminated cases 1.Management
First-line treatment: Ivermectin is highly effective; administer at a dosage of 200 micrograms/kg of body weight 1.
Duration: Treatment typically requires prolonged courses, often several weeks, depending on the severity and immune status of the patient 1.
Adjunctive measures: Supportive care including management of complications such as sepsis or respiratory failure 1.Special Populations
Immunocompromised patients: Require aggressive and prolonged treatment with ivermectin due to higher risk of hyperinfection syndrome 1.
Specific dosing noted: No explicit pediatric, elderly, or pregnancy-specific dosing provided in the abstracts 1.Key Recommendations
Use ivermectin at 200 micrograms/kg for treatment of disseminated strongyloidiasis (Evidence: Strong 1).
Monitor for and manage complications such as arteritis and systemic infection, particularly in immunocompromised individuals (Evidence: Moderate 1).
Consider prolonged treatment courses tailored to patient immune status and clinical response (Evidence: Expert opinion 1).References
1 Slocombe JO, McCraw BM, Pennock PW, Vasey J. Effectiveness of ivermectin against later 4th-stage Strongylus vulgaris in ponies. American journal of veterinary research 1982. link